Thomas Catinazzo sold $331K of Relay Therapeutics (RLAY)

Executed Jul 6, disclosed Jul 8, 2 days later.

Value, as filed

$331K

17,717 sh × $18.69

Executed

Jul 6

the trade date, as filed

Disclosed

Jul 8

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Thomas Catinazzo Chief Financial Officer profile →

Thomas Catinazzo (Chief Financial Officer) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in Relay Therapeutics, Inc. (RLAY). The largest single filing was $3.2M of RLAY (187,163 sh across 4 lots, as filed), executed Jun 22.

The name

RLAY

Relay Therapeutics, Inc. RLAY · Healthcare · 32 filings in 24 months ticker →

Healthcare · Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Thomas Catinazzo in RLAY

RLAYSALE Relay Therapeutics, Inc. $336K
17,717 sh × $18.94
Exec Sep 8
Filed Sep 9 · 4:15 PM ET RLAYSALE Relay Therapeutics, Inc. $350K
17,717 sh × $19.74
Exec Aug 14
Filed Aug 18 · 4:16 PM ET RLAYSALE Relay Therapeutics, Inc. $3.2M
187,163 sh across 4 lots
Exec Jun 22
Filed Jun 24 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. $228K
17,717 sh × $12.86
Exec May 14
Filed May 14 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. $230K
17,717 sh × $13.01
Exec Apr 7
Filed Apr 9 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. $178K
17,717 sh × $10.06
Exec Mar 9
Filed Mar 11 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. $105K
13,820 sh × $7.62
Exec Jan 27
Filed Jan 29 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. $158K
21,664 sh × $7.29
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET